Assessment of the role of Ga-68 PSMA I&T PET/CT in response evaluation to docetaxel therapy in castration resistant prostate cancer patients

2020 ◽  
Vol 39 (5) ◽  
pp. 292-298
Author(s):  
Tamer Özülker ◽  
Filiz Özülker
Keyword(s):  
Prostate Cancer ◽  
Cancer Patients ◽  
Response Evaluation ◽  
Castration Resistant Prostate Cancer ◽  
Castration Resistant ◽  
Pet Ct

Prognostic role of neutrophil-to-lymphocyte ratio in castration-resistant prostate cancer patients treated with docetaxel.

2015 ◽  
Vol 33 (15_suppl) ◽  
pp. e16050-e16050
Author(s):  
Atike Pinar ◽  
Ahmet Ozveren ◽  
Zeki Gokhan Surmeli ◽  
Ulus Ali Sanli ◽  
Ruchan Uslu ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Cancer Patients ◽  
Neutrophil To Lymphocyte Ratio ◽  
Castration Resistant Prostate Cancer ◽  
Prognostic Role ◽  
Lymphocyte Ratio ◽  
Castration Resistant

11C-Choline PET/CT in castration-resistant prostate cancer patients treated with docetaxel

2015 ◽  
Vol 43 (1) ◽  
pp. 84-91 ◽  
Author(s):  
Francesco Ceci ◽  
Paolo Castellucci ◽  
Tiziano Graziani ◽  
Riccardo Schiavina ◽  
Riccardo Renzi ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Cancer Patients ◽  
Castration Resistant Prostate Cancer ◽  
Choline Pet ◽  
Castration Resistant ◽  
Pet Ct

Role of chemotherapy in the treatment of metastatic castration-resistant prostate cancer patients who have progressed after abiraterone acetate

2015 ◽  
Vol 76 (3) ◽  
pp. 439-445 ◽  
Author(s):  
Roberto Petrioli ◽  
Edoardo Francini ◽  
Letizia Laera ◽  
Anna Ida Fiaschi ◽  
Roberto Ponchietti ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Cancer Patients ◽  
Abiraterone Acetate ◽  
Castration Resistant Prostate Cancer ◽  
Castration Resistant

scholarly journals Early outcome prediction on 18F-fluorocholine PET/CT in metastatic castration-resistant prostate cancer patients treated with abiraterone

Oncotarget ◽  
2014 ◽  
Vol 5 (23) ◽  
pp. 12448-12458 ◽  
Author(s):  
Ugo De Giorgi ◽  
Paola Caroli ◽  
Salvatore L. Burgio ◽  
Cecilia Menna ◽  
Vincenza Conteduca ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Cancer Patients ◽  
Outcome Prediction ◽  
Castration Resistant Prostate Cancer ◽  
Early Outcome ◽  
Castration Resistant ◽  
Pet Ct

Prognostic role of early PSA drop in castration resistant prostate cancer patients treated with abiraterone acetate or enzalutamide

2020 ◽  
Vol 72 (6) ◽  
Author(s):  
Consuelo Buttigliero ◽  
Marcello Tucci ◽  
Cristina Sonetto ◽  
Francesca Vignani ◽  
Rosario F. Di Stefano ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Cancer Patients ◽  
Abiraterone Acetate ◽  
Castration Resistant Prostate Cancer ◽  
Prognostic Role ◽  
Castration Resistant
Sign in / Sign up

Export Citation Format

Share Document